§ PHARMACEUTICALS
USD · Pharmaceuticals

HRMY

HARMONY BIOSCIENCES HOLDINGS
USDSector · PharmaceuticalsBeta · 0.97
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
187 increased/new, 110 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/E10.1P/B2.48
EPS (TTM)2.71
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.7.1M0.0%−0%
Fidelity Management3.2M0.0%+1%
VANGUARD PORTFOLIO MANAGEMENT LLC2.7Mn/an/a
AMERICAN CENTURY COMPANIES INC2.1M0.0%+14%
VANGUARD CAPITAL MANAGEMENT LLC2.1Mn/an/a
Dimensional Fund Advisors2.1M0.0%+13%
◇ AC INTELLIGENCE

Top institutional owners for HRMY as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER43.0% · 212 holders
PASSIVE / INDEX17.4% · 10 holders
QUALITY / COMPOUNDER16.5% · 21 holders
DEALER / BANK14.5% · 29 holders
SYSTEMATIC / QUANT5.1% · 10 holders
TACTICAL / MACRO3.7% · 6 holders
INCOME / DEFENSIVE1.6% · 20 holders
ACTIVIST0.2% · 1 holder
DEEP VALUE0.1% · 2 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for HRMY in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention HRMY yet.